Lazard Asset Management
IDYA icon

Lazard Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Lazard Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,502
Closed -$63K – 2419
2022
Q4 		$63K Buy
+3,502
New +$58.9K ﹤0.01% 1701
2022
Q3 		– Sell
-12,027
Closed -$165K – 2431
2022
Q2 		$165K Buy
+12,027
New +$134K ﹤0.01% 1332
2021
Q3 		– Sell
-1,874
Closed -$39K – 2210
2021
Q2 		$39K Hold
1,874
– – ﹤0.01% 1692
2021
Q1 		$44K Buy
+1,874
New +$36.2K ﹤0.01% 1497

Other funds holding IDYA

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's IDYA Position: Q1 2023 in Review

Lazard Asset Management sold out of IDEAYA Biosciences (IDYA) in Q1 2023, closing a stake of 3,502 shares — an estimated $63K sold.

Lazard Asset Management first reported a position in IDYA in Q1 2021 and held it in 4 quarters. The position peaked at $165K in Q2 2022. 128 funds tracked by Wall St. Rank hold IDYA as of Q1 2023.

  • Lazard Asset Management reported no remaining IDEAYA Biosciences position as of Q1 2023 after selling out during the quarter.
  • Lazard Asset Management sold 3,502 IDEAYA Biosciences shares in Q1 2023, an estimated $63K.
  • Lazard Asset Management first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 4 quarters.
  • Lazard Asset Management's IDEAYA Biosciences position peaked at $165K in Q2 2022.
  • 128 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2023.

Based on Lazard Asset Management's 13F filing for Q1 2023, filed 15 May 2023.